Under construction – not a live service
Sign in
Taking people in NorwayNo phase

Immune Responses After Stroke and Later Thinking Decline

Studies immune responses in adults after stroke, looking at possible links to memory decline.

Plain-language title generated from the registry record
Registry title: The Immune Response to Stroke

Key facts

Where
Lørenskog, NorwaySee the site

Where in Norway

  • Akershus University HospitalLørenskog, NorwayTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Oslo
Trial code
NCT05277129
Record updated
14 March 2022
Original description
Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.Read full original descriptionShow less

The Immune Response to Stroke

Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.

Inclusion: Stroke < 72 h; Age > 18 years.

Exclusion: Previous or present immunological disease or other serious comorbidity; Brain hemorrhage verified by CT or MRI scan; Ongoing immune respons after infection or vaccination < 1 month; Cognitive without ability to understand and/or give an informed consent to participate in the study.

ClinicalTrials.gov NCT05277129